KENNEDY INVESTMENT GROUP, INC.

Position in ABBV — AbbVie Inc.

CIK 1978005 WEST DEPTFORD, NJ

Position in ABBV

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$3,964,336

+$622,168 QoQ

Shares Held

15,754

+2.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.95%

of 13F equity value

Holder Rank

#1,459

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

KENNEDY INVESTMENT GROUP, INC. holds $14,260,907 across 7 Drug Manufacturers - General names. ABBV ranks #1 (27.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	15,754	$3,964,336
2	NVO	Novo Nordisk A S	69,531	$3,333,316
3	LLY	ELI LILLY & Co	2,744	$3,291,236
4	JNJ	Johnson & Johnson	6,591	$1,673,916
5	NVS	Novartis AG	5,972	$935,931
6	AMGN	Amgen Inc	1,946	$704,685
7	MRK	Merck & Co., Inc.	2,782	$357,487

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,964,336	15,754	+2.5%	Shares	Sole	2026-07-30
2026-03-31	$3,342,168	15,367	+1.5%	Shares	Sole	2026-04-22
2025-12-31	$3,457,739	15,133	+0.0%	Shares	Sole	2026-02-06
2025-09-30	$3,502,505	15,127	-0.1%	Shares	Sole	2025-10-28
2025-06-30	$2,810,101	15,139	-0.6%	Shares	Sole	2025-07-16
2025-03-31	$3,191,199	15,231	-1.1%	Shares	Sole	2025-04-22
2024-12-31	$2,736,580	15,400	+12.7%	Shares	Sole	2025-01-22
2024-09-30	$2,699,156	13,668	-0.3%	Shares	Sole	2024-10-21
2024-06-30	$2,351,710	13,711	+5.6%	Shares	Sole	2024-07-18
2024-03-31	$2,364,022	12,982	-6.7%	Shares	Sole	2024-04-22
2023-12-31	$2,156,562	13,916	+10.8%	Shares	Sole	2024-01-29
2023-09-30	$1,872,491	12,562	-5.1%	Shares	Sole	2023-10-25
2023-06-30	$1,783,151	13,235	-9.2%	Shares	Sole	2023-07-19
2023-03-31	$2,322,339	14,572	+0.5%	Shares	Sole	2023-06-01
2022-12-31	$2,342,213	14,493	—	Shares	Sole	2023-06-01
No filing history on record for this holder in this stock.